Introduction Initially developed as glucose-lowering drugs, glucagon-like peptide-1 receptor agonists (GLP-1RAs) have emerged as multipurpose therapeutics, extending their reach from type 2 diabetes to obesity and liver disease 1,2
For example, aspirin can cause gastrointestinal problems such as stomach irritation, heartburn, or even ulcers
Report the product to the FDA MedWatch program at www.fda.gov/medwatch or by calling 1-800-FDA-1088
If constipation is a specific issue, see the GLP-1 constipation reset
Each time you eat, your body naturally releases hormones that signal fullness, and our treatments help optimize those signals so you can manage appetite, stay satisfied longer, and lose weight more successfully
Glucagon actually increases blood sugar, but when you combine it with a GLP-1, it can actually increase energy use and fat burning